Souhaitez-vous accéder aux communiqués récents ?

Solide performance au deuxième trimestre et forte progression du portefeuille R&D, Hausse des perspectives 2023 Paris, le 28 juillet 2023 T2 2023 : Augmentation des ventes de 3,3% à TCC et...

Solid Q2 performance and strong pipeline momentum, Full-year 2023 business EPS guidance raised Paris, July 28, 2023 Q2 2023 sales growth of 3.3% at CER and business EPS(1) growth of 8.1% at CER ...

CHATHAM, N.J., July 27, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical company, today announced it has entered into a...

Tinlarebant (a/k/a LBS-008) is Belite Bio’s orally administered tablet intended to slow disease progression in subjects with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry...

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the U.S. Department of Health and Human...

Nyxoah Participera à la 43ème Canaccord Genuity Growth Conference Mont-Saint-Guibert, Belgique – 27 juillet 2023, 22:30 CET / 16:30 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la...

Nyxoah to Participate in the 43rd Canaccord Genuity Growth Conference Mont-Saint-Guibert, Belgium – July 27, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or...

Nyxoah Publiera ses Résultats Financiers pour le Deuxième Trimestre 2023 le 8 Août 2023 Mont-Saint-Guibert, Belgique – 27 juillet 2023, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq :...

Nyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023 Mont-Saint-Guibert, Belgium – July 27, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah”...

AUSTIN, Texas, July 27, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced...

CHATHAM, N.J., July 27, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical company, today announced that it intends to offer...

LEXINGTON, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS) is re-issuing this press release solely to correct inadvertent typographical errors. The...

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Outset Medical, Inc. (“Outset Medical” or the “Company”) (NASDAQ: OM). Such investors are...

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc. Shareholders who purchased shares of RAIN during the class period...

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of ImmunityBio, Inc. Shareholders who purchased shares of IBRX during the class period...

New York, USA, July 27, 2023 (GLOBE NEWSWIRE) -- Non-small Cell Lung Cancer Market is Projected to Boost by 2032, Predicts DelveInsight | Key Companies Working in Space - AstraZeneca, BMS, AbbVie,...

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of BioXcel Therapeutics, Inc. Shareholders who purchased shares of BTAI during the class...

Rockville, July 27, 2023 (GLOBE NEWSWIRE) -- As per Fact.MR, a provider of market research and competitive intelligence, The Skin Care Ingredients Market is expected to witness a market value of USD...

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December 15,...

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX), and certain...

Ottawa, July 27, 2023 (GLOBE NEWSWIRE) -- The global CAR T-Cell therapy market revenue was valued at USD 3,827 million in 2022, a study published by Towards Healthcare a sister firm of Precedence...

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between May 23, 2022 and...

LONDON and NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease...

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Rain...

BENSALEM, Pa., July 27, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...

LOS ANGELES, July 27, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming August 18, 2023 deadline to file a lead plaintiff motion in the class action...

EDINBURGH, Scotland, July 27, 2023 (GLOBE NEWSWIRE) -- Blackford, the pioneering strategic imaging AI platform and solutions provider, and Lunit Inc, a chest Xray and mammography AI provider...

Hyderabad, July 27, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled “In Vitro Diagnostic Market Report (2023-2028),” the market is estimated at USD 97.12 billion in 2023....

New York, July 27, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Functional Cosmetics Market by Functionality, Application And Region - Global Forecast to 2028" -...

Westford USA, July 27, 2023 (GLOBE NEWSWIRE) -- According to SkyQuest, the rise in the prevalence of amyotrophic lateral sclerosis treatment market has driven a surge in demand for effective...

SAN DIEGO, July 27, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat...

Southlake, Texas, July 27, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based...

Rockville , July 27, 2023 (GLOBE NEWSWIRE) -- The revenues of the cell therapy technologies market were estimated at US$ 4.5 Billion in 2022 and are anticipated to grow at a CAGR of 14.4% from 2023...

RADNOR, Pa., July 27, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the...

MIAMI, July 27, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of...

Chicago, July 27, 2023 (GLOBE NEWSWIRE) -- In the near future, the molecular diagnostics industry is poised to experience revolutionary advancements that will profoundly shape healthcare practices...

MINNEAPOLIS, July 27, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...

Combined company to operate as Ayala Pharmaceuticals, Inc. Merger to add a clinical stage oncology asset to Ayala’s portfolio with data anticipated in the first half of 2024 REHOVOT and TEL...

Preliminary data suggest a chlamydia, gonorrhea and trichomonas (CT/NG/TV) multiplex test is feasible on a molecular point-of-care (POC) test system with time to result in less than 30 minutes ...

NEW YORK and LONDON, July 27, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory...

Dallas, Texas, July 27, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men’s health and...

New York, July 27, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Antimicrobial Plastic Market- Global Industry Size, Share, Trends, Opportunity, and Forecast,...

NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...

55% objective response rate; 23% complete response rate in locally advanced cSCC 50% objective response rate; 13% complete response rate in metastatic cSCC Cosibelimab continues to demonstrate a...

Interim safety data from the Phase 2 DAVIO 2 trial continues to demonstrate EYP-1901 is well tolerated with no reported drug-related ocular or systemic SAEs Patient demographics demonstrate the Phase...

Reports positive topline data from latest pilot pharmacokinetic (PK) studyPlans to submit pivotal PK clinical study protocol to the FDA in early AugustAnticipates commencement of its definitive...

WOBURN, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported business and financial highlights for the quarter and six months period ended June 30, 2023. The...

New York, July 27, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Nanosilica Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F," -...

Dublin, July 27, 2023 (GLOBE NEWSWIRE) -- The "Global Vaccine Delivery Devices Market 2023-2028 by Type, End-User, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report...

Westford, USA, July 27, 2023 (GLOBE NEWSWIRE) -- According to SkyQuest's latest global research of the Orthopedic Implant market, advancements in implant materials and coatings, robotic-assisted...